Correlation Between Stelar Metals and Bio-Gene Technology

Can any of the company-specific risk be diversified away by investing in both Stelar Metals and Bio-Gene Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stelar Metals and Bio-Gene Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Stelar Metals and Bio Gene Technology, you can compare the effects of market volatilities on Stelar Metals and Bio-Gene Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stelar Metals with a short position of Bio-Gene Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stelar Metals and Bio-Gene Technology.

Diversification Opportunities for Stelar Metals and Bio-Gene Technology

0.32

Correlation Coefficient

Stelar Metals  Bio-Gene Technology

Weak diversification

The 3 months correlation between Stelar and Bio-Gene is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Stelar Metals and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and Stelar Metals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stelar Metals are associated (or correlated) with Bio-Gene Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of Stelar Metals i.e., Stelar Metals and Bio-Gene Technology go up and down completely randomly.

Pair Corralation between Stelar Metals and Bio-Gene Technology

Assuming the 90 days trading horizon Stelar Metals is expected to under-perform the Bio-Gene Technology. But the stock apears to be less risky and, when comparing its historical volatility, Stelar Metals is 4.25 times less risky than Bio-Gene Technology. The stock trades about -0.06 of its potential returns per unit of risk. The Bio Gene Technology is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  3.90  in Bio Gene Technology on December 21, 2024 and sell it today you would lose (0.60) from holding Bio Gene Technology or give up 15.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Stelar Metals  vs.  Bio Gene Technology

Stelar Metals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Stelar Metals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental drivers remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Bio Gene Technology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bio Gene Technology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Bio-Gene Technology may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Stelar Metals and Bio-Gene Technology

The main advantage of trading using opposite Stelar Metals and Bio-Gene Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stelar Metals position performs unexpectedly, Bio-Gene Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio-Gene Technology will offset losses from the drop in Bio-Gene Technology's long position.

The idea behind Stelar Metals and Bio Gene Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.